Back |
home / stock / fldm / fldm message board
Subject | By | Source | When |
---|---|---|---|
Never stop learning lessons. Priceless. | Inspector121 | investorshub | 08/27/2020 7:01:23 PM |
I rarely pick it right either, but this | Ckasper | investorshub | 08/27/2020 7:00:08 PM |
Great call. Wish I had the knowledge to | Inspector121 | investorshub | 08/27/2020 6:58:45 PM |
Accuracy of that test is questionable. But BP | Inspector121 | investorshub | 08/27/2020 6:16:22 PM |
WHOA! my $7.65 buys this morning starts to | lakingsphan0427 | investorshub | 08/27/2020 5:56:57 PM |
That was a fleeting moment of hype, | Runners123 | investorshub | 08/27/2020 3:49:42 PM |
I'm at an avg. of $9.41 and feel | Daddy Rick | investorshub | 08/27/2020 3:46:34 PM |
Bittersweet, I was fine with 1000 shares | sfast900 | investorshub | 08/27/2020 3:09:19 PM |
Itll bottom at 7.50. Then go back to | Ckasper | investorshub | 08/27/2020 2:41:48 PM |
Thank You. | Daddy Rick | investorshub | 08/27/2020 2:41:40 PM |
Abbott tests highly inaccurate. | Inspector121 | investorshub | 08/27/2020 2:39:31 PM |
Is this worth getting into? Looks like it | ib12u | investorshub | 08/27/2020 2:39:09 PM |
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...
Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025 Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLO...